Brief: Camurus Reiterates Outlook For 2026
15/07/2026 06:04
BRIEF-Camurus Reiterates Outlook For 2026 July 15 (Reuters) - Camurus AB CAMX.ST:
CAMURUS Q2 REVENUE SEK 702 MILLION VERSUS. IBES ESTIMATE SEK 632.8 MILLION
CAMURUS Q2 EBIT SEK 293 MILLION
2026 OUTLOOK: REITERATED
Q2 TOTAL REVENUES INCREASED 4% (3% AT CER(1)) TO MSEK 702 (676)
ON FDA: OUTSTANDING FDA COMMENTS HAVE BEEN ADDRESSED, AND WE EXPECT TO PROVIDE A FURTHER REGULATORY UPDATE SHORTLY
Source text: ID:nWkr9hTkhK
Further company coverage: CAMX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Camurus AB
See all newsBrief: Camurus Receives Approval In Canada For Oczyesa XR
Brief: Executive Sells About £279,000 Of Camurus Shares
Jefferies cuts Ipsen to 'underperform' on Somatuline competition risk
Brief: Camurus Says NDA Resubmission For CAM2029 In Acromegaly Accepted For Review By FDA
Camurus shares rise after Q2 revenue, operating profit beat